...
首页> 外文期刊>Tissue engineering, Part A >Xenogenic transplantation of human mesenchymal stem cells in a critical size defect of the sheep tibia for bone regeneration.
【24h】

Xenogenic transplantation of human mesenchymal stem cells in a critical size defect of the sheep tibia for bone regeneration.

机译:人间充质干细胞的异种移植在绵羊胫骨的临界尺寸缺损处进行骨再生。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Mesenchymal stem cells (MSCs) represent an attractive cell population for the regeneration of mesenchymal tissues. Their special immunological characteristics suggest that MSCs could be used in nonautologous applications. In this study, the regenerative capacity of human and ovine MSCs was assessed in an ovine critical size defect model. Human and ovine MSCs from bone marrow were cultured on mineralized collagen and implanted into a 3.0-cm-long sheep tibia bone defect (n = 7). Unloaded mineralized collagen served as control. Bone healing was assessed until euthanasia 26 weeks after surgery by radiology and histologically after euthanasia. The presence of human cells after xenogenic transplantation was analyzed using human-specific in situ hybridization. Both radiology and histology demonstrated significantly better bone formation after transplantation of autologous ovine MSCs on mineralized collagen compared with unloaded matrices and with the xenogenic treatment group. Nevertheless, no local or systemic rejection reactions could be observed after transplantation of human MSCs, although the presence of human MSCs could be demonstrated. It can be concluded that despite successful demonstration of the presence of human MSCs after xenogenic transplantation, the xenogenic transplantation of human MSCs leads to poorer bone regeneration than autologous transplantation of ovine MSCs.
机译:间充质干细胞(MSCs)代表了一种吸引人的细胞群,用于间充质组织的再生。它们的特殊免疫学特征表明,MSCs可用于非自体应用。在这项研究中,在绵羊临界尺寸缺损模型中评估了人类和绵羊MSC的再生能力。将人和绵羊的骨髓间充质干细胞在矿化的胶原蛋白上培养,然后植入3.0厘米长的绵羊胫骨骨缺损(n = 7)。卸载的矿化胶原蛋白作为对照。通过放射学和安乐死后的组织学评估骨愈合直至术后安乐死26周。使用人特异性原位杂交分析异种移植后人细胞的存在。与空载基质和异种治疗组相比,放射学和组织学均显示自体绵羊MSCs在矿化胶原蛋白上移植后的骨形成明显改善。然而,尽管可以证明存在人类MSC,但是在人类MSC移植后没有观察到局部或全身排斥反应。可以得出结论,尽管成功地证明了异种移植后人类MSC的存在,但与绵羊MSC的自体移植相比,人类MSC的异种移植导致的骨再生更差。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号